Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis - Peer Mentor Training

Chronic Disease Clinical Trial

Official title:

Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis - Peer Mentor Training

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01054963
• Other study ID #: 419-2009
• Status: Completed
• Phase: N/A
• First received: January 21, 2010
• Last updated: December 23, 2011
• Start date: January 2010
• Est. completion date: December 2011

Study information

• Verified date: December 2011
• Source: Sunnybrook Health Sciences Centre
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

Inflammatory arthritis (IA) is a major cause of long-term disability. Peer support may be a solution to the common problem of delayed treatment. Early peer support may result in improved use of therapy, higher self-efficacy, reduced anxiety, and improved coping in the first two years post-diagnosis. This study involves the development and testing of a peer mentor training initiative as one part of an intervention study for people with early IA (EIA). Peer mentors will be trained and assessed to provide one-on-one support (information, emotional, feedback) to individuals who have recently been diagnosed with IA. This is one part of an intervention study. The other part is called Peer to Peer Mentoring: Facilitating Individuals with Early Inflammatory Arthritis to Manage their Arthritis - Peer Mentoring Program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: December 2011
• Est. primary completion date: September 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• To become a peer mentor are:

1. Diagnosis of IA from a physician

2. Disease duration more than 2 years and managing well

3. Currently using medications (DMARDS/biologics) to treat arthritis

4. Have completed an Arthritis Self-Management Program (ASMP) provided by The Arthritis Society and/or similar program and/or have sufficient knowledge and experience with teaching or providing mentoring support to an individual living with a chronic disease

5. Able to participate in two approximately 5-hour training workshops

6. Able to take part in ongoing assessment/evaluation activities (self-report questionnaire, interviews, observation, study activity log)

7. Able to commit to the duration of the research study

8. Willing to provide ongoing one-on-one support to an individual newly diagnosed with IA

9. 18 years of age or older

10. Able to speak, understand, read and write English

Exclusion Criteria:

• Do not meet inclusion criteria

Study Design

Intervention Model: Single Group Assignment, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Arthritis
• Chronic Disease
• Early Inflammatory Arthritis

Intervention

Behavioral:
• peer mentor training
A quasi-experimental, before and after study design is proposed to obtain data for planning and implementing a larger-scale study. A training workshop for individuals with IA to become peer mentors will increase peer mentors' confidence and skills to provide one-on-one support to individuals with EIA. Using a combination of lectures, experiential learning and question/answer sessions, peer mentors will learn and practice informational, emotional, appraisal support techniques and skills (communication skills, problem-solving strategies, use of decision tools). Training will be conducted face-to-face, in small-group format by research team and others (2 sessions approx. 5 hours each), in a private meeting room at SHSC. Peer mentors will then provide support to individuals newly diagnosed with IA for 12 weeks (once per week) by telephone and /or face-to-face. Peer mentors will receive ongoing support from the research team (telephone, meetings).

Locations

Country	Name	City	State
Canada	Sunnybrook Health Sciences Centre	Toronto	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Sunnybrook Health Sciences Centre	Canadian Arthritis Network

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ability to provide informational, appraisal and emotional support		0, 3, 6 months	No
Secondary	confidence to provide informational, appraisal and emotional support		0, 3, 6 months	No